HekaBio is an ecosystem for a healthcare development platform that provides therapeutic treatments in oncology and ophthalmology.
HekaBio's investors include Ohara Pharmaceutical, Essential Pharma, Alfresa Holdings, Media Future, Toho Holdings.
HekaBio is headquartered in Tokyo, Japan.
HekaBio is an ecosystem for a healthcare development platform that provides therapeutic treatments in oncology and ophthalmology.
HekaBio is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HekaBio — Funding & Investors." VCBacked, June 16, 2025, https://www.vcbacked.co/company/hekabio. Accessed September 30, 2026.
VCBacked. (2025). HekaBio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/hekabio
{{cite web |title=HekaBio — Funding & Investors |url=https://www.vcbacked.co/company/hekabio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated